Gvh-459

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

: Modern treatments like post-transplant cyclophosphamide (PTCy) are used to prevent severe cases.

In medical literature, "GVH-459" or "459" often refers to specific patient cohorts or data points within larger studies on bone marrow transplants. GVH-459

Institutional Context: GVH (Hungarian Competition Authority)

: Clinical reviews often use similar numeric identifiers for patient sub-groups to validate risk scores for acute GVHD, which helps predict steroid therapy response and mortality risks. This is for informational purposes only

: In recent multicenter registry data (January 2017 – June 2021), a group of 459 adult patients receiving mismatched unrelated donor (MMUD) transplants with calcineurin inhibitor (CNI)-based prophylaxis was studied.

: Monitoring unfair commercial practices. : In recent multicenter registry data (January 2017

If your query relates to the medical condition itself, GVHD is a complication of allogeneic transplants where donor immune cells attack the recipient's body.